Friday, April 19, 2024 3:56:01 PM
Summary: LTIs came in October 2017 to: Cure (the delayed filings ),positively conclude litigation in order to then return to normal trading and normal business . Growth cannot commence until above then growth, Ultimately as final goal as seen by LTIs, “to NASDAQ.” Into fiscal year 2024, the Company is still returning to normal business , and beginning the growth segment.
Only those who haven’t a clue and never accomplished anything in a public company, will spew timetables and the their tattered opinions.
The Company did exactly what was stated and completed all aspects of cure , elimination of all litigation to benefit of Company and returning to normal trading and normal business as stated in PRs and Updates. And of course filed all necessary SEC reports as part of normal business , before and now coincident , with any growth including geographic expansion could begin.
The foundation for growth has been building since the beginning of the 2024 fiscal year.
DBMM has stated sustainability is key and with all impediments positively removed to the Company’s benefit, the Company is building into the US and the foundation is being drilled down.
Each quarter is improving and shareholders are supportive , now the larger increases and surprises as was the case with previous wins.
Bashers know nothing, check each one out is archives, many trolling different companies, who say the exact same things from a template. Paid for play, and stupidity squared. Shareholders know so much more with documentation-than naysayers.
Go DBMM
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM